Refractory HIV Associated Kaposi Sarcoma research hub

Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma

This study tests a new drug, dostarlimab, for a rare cancer called Kaposi Sarcoma in people with HIV whose cancer hasn't responded to usual treatments. It will check if the drug is safe and how well it works.